Vitamin A and D Supplementation in Allogeneic HCT

NCT06508099 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Biphenotypic Acute Leukemia
Lymphoblastic Lymphoma
Chronic Myeloid Leukemia
Myelodysplastic Syndromes
Myeloprolipherative Neoplsm
Non-hodgkin Lymphoma

Interventions

DRUG: Vitamin A
DRUG: Vitamin D3

Sponsor

St. Petersburg State Pavlov Medical University